This episode of The Motley Fool's Market Checkup is dedicated to the world's largest health-care conglomerate, Johnson & Johnson (NYSE: JNJ ) . Market Checkup gives a full examination of J&J's second-quarter results and takes a closer look at the company's three main business segments: medical devices and diagnostics, pharmaceuticals, and consumer.
In this video, health-care analysts David Williamson and Max Macaluso drill down on medical devices and diagnostics, J&J's largest segment. Watch and find out why the company's reported growth may not be as strong as it appears, and why this division may get a name change in the not too distant future.
One of the best parts of owning Big Pharma stocks is their attractive dividends, but smart investors know the importance of diversifying -- seeking high-yielding stocks from multiple industries. The Motley Fool's special free report "Secure Your Future With 9 Rock-Solid Dividend Stocks" outlines the Fool's favorite dependable dividend-paying stocks across all sectors. Grab your free copy by clicking here.